B

Bonus Biogroup Ltd
TASE:BONS

Watchlist Manager
Bonus Biogroup Ltd
TASE:BONS
Watchlist
Price: 9.9 ILS 1.02% Market Closed
Market Cap: 121.1m ILS
Have any thoughts about
Bonus Biogroup Ltd?
Write Note

Bonus Biogroup Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bonus Biogroup Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
B
Bonus Biogroup Ltd
TASE:BONS
Other Long-Term Assets
â‚Ş374k
CAGR 3-Years
-7%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Other Long-Term Assets
$57k
CAGR 3-Years
-32%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Other Long-Term Assets
$143.2m
CAGR 3-Years
157%
CAGR 5-Years
146%
CAGR 10-Years
107%
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Other Long-Term Assets
$406k
CAGR 3-Years
65%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Other Long-Term Assets
$545k
CAGR 3-Years
-35%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Other Long-Term Assets
$20k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bonus Biogroup Ltd
Glance View

Market Cap
121.1m ILS
Industry
Biotechnology

Bonus Biogroup Ltd. is a biotechnology company engaging in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.

BONS Intrinsic Value
0.41 ILS
Overvaluation 96%
Intrinsic Value
Price
B

See Also

What is Bonus Biogroup Ltd's Other Long-Term Assets?
Other Long-Term Assets
374k ILS

Based on the financial report for Jun 30, 2024, Bonus Biogroup Ltd's Other Long-Term Assets amounts to 374k ILS.

What is Bonus Biogroup Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
31%

Over the last year, the Other Long-Term Assets growth was 1%. The average annual Other Long-Term Assets growth rates for Bonus Biogroup Ltd have been -7% over the past three years , 31% over the past five years .

Back to Top